利用孕妇干血斑进行早孕期无创胎儿RHD基因分型
本研究评估孕妇干血斑作为早孕期筛查与胎儿RHD基因分型联合一步检测来源的可行性,对19例RhD阴性孕妇采集干血斑和外周血,用实时PCR检测胎儿RHD基因型并与产后血清学结果比对。19例RHD基因分型全部与产后血清学一致,灵敏度、特异度、阳性预测值、阴性预测值均为100%;胎儿性别18/19例判断正确。
要点
- 19例RhD阴性孕妇干血斑胎儿RHD基因分型与产后血清学结果全部一致。
- 胎儿RHD基因分型灵敏度、特异度、阳性预测值、阴性预测值均为100%。
- 干血斑胎儿性别判断18/19例正确,1例女胎误判为男胎。
核心结论
- 孕妇干血斑具有样本运输和处理灵活的优点,可用于无创产前胎儿RHD基因分型,并有可能纳入常规早孕期筛查。
- 作者指出正在开展更大规模研究以将胎儿RHD基因分型纳入常规产前保健。
研究设计与样本
- 研究纳入19例RhD阴性孕妇,在早孕期筛查时同时采集孕妇干血斑和外周血样本。
- 提取DNA后用序贯实时PCR测定胎儿RHD基因型,产后获得胎儿RhD血清学类型。
- 研究经机构审查委员会批准,并获得知情同意。
主要发现
- 19/19例干血斑胎儿RHD基因分型与产后随访血清学RhD检测结果一致。
- 11例为RhD阳性,8例为RhD阴性(RHD缺失或RHD-CE-D 6例,RHD假基因1例,RHDVI 1例)。
- 胎儿RHD基因分型灵敏度=100%,特异度=100%,阳性预测值=100%,阴性预测值=100%。
- 干血斑胎儿性别判断18/19例正确,1例女胎被误判为男胎。
- 胎儿性别判断灵敏度=100%,特异度=91.6%,阳性预测值=87.5%,阴性预测值=100%。
临床怎么用
- 作者认为孕妇干血斑可用于无创产前胎儿RHD基因分型,并可能纳入常规早孕期筛查。
局限性
- 作者指出正在开展更大规模研究以将胎儿RHD基因分型纳入常规产前保健。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study was aimed to evaluate whether maternal dried blood spots could be a potential source for the noninvasive fetal RHD genotyping, serving as a combined one-step test for both the First Trimester Screen and the fetal RHD genotyping. METHOD: Both the maternal dried blood spots and the peripheral blood samples from 19 RhD-negative pregnant women were obtained during the First Trimester Screen. DNA was extracted and sequential real-time PCRs were performed to determine the fetal RHD genotypes. Fetal RhD serological types were obtained after delivery. This study was approved by the Institutional Review Board, and informed consents were obtained. RESULTS: A total of 19/19 fetal RHD genotyping with maternal DBS were consistent with the follow-up serological RhD test results after birth. Eleven were RhD positive, and eight were RhD negative (RHD deletion or RHD-CE-D = 6, RHD pseudogene = 1, RHDVI = 1). Sensitivity = 100%, specificity = 100%, positive predictive value = 100%, negative predictive value = 100%. A total of 18/19 fetal gender were determined correctly with maternal DBS. One female fetus was falsely determined as male. Sensitivity = 100%, specificity = 91.6%, positive predictive value = 87.5%, negative predictive value = 100%. CONCLUSION: Maternal dried blood spots, with the benefits of flexible sample transportation and processing, could be utilized for the noninvasive prenatal fetal RHD genotyping and potentially be incorporated into the routine First Trimester Screen. Larger scale study is in progress to implement fetal RHD genotyping in routine prenatal care. © 2017 John Wiley & Sons, Ltd.
引用
- Xiong Y, Jeronis S, Hoffman B, et al. First trimester noninvasive fetal RHD genotyping using maternal dried blood spots. Prenat Diagn. 2017. PMID: 28081297. doi:10.1002/pd.5006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。